---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-133817"
form_type: "8-K"
ticker: "RKDA"
cik: "0001469443"
company_name: "Arcadia Biosciences, Inc."
filed_at: "2024-12-06T23:59:59+00:00"
generated_at: "2026-05-29T06:17:35.106380+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Arcadia Biosciences to combine with Roosevelt Resources in all-stock reverse merger; Roosevelt owners to get ~90%

## Summary
- Arcadia to issue shares for all Roosevelt equity; current Arcadia shareholders will own ~10% of combined company.
- Roosevelt's primary asset: 16,208-acre CCUS oil and gas project in Texas Permian Basin.
- Combined company management: Elliott Roosevelt Jr. as CEO, Jimmy Hawkins as President, Jerrel Branson as CFO.
- Name change to Roosevelt Resources, Inc.; closing expected Q1 2025, subject to shareholder and regulatory approvals.
- Arcadia had conducted strategic review since July 2023; deal advised by Lake Street Capital and Roth Capital.

## SEC filing metadata
- accession: 0000950170-24-133817
- form_type: 8-K
- ticker: RKDA
- cik: 0001469443
- company_name: Arcadia Biosciences, Inc.
- filed_at: 2024-12-06T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 5.01, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1469443/000095017024133817/0000950170-24-133817-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1469443/000095017024133817/rkda-20241204.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-133817
- JSON: https://secwatch.observer/filing/0000950170-24-133817.json
- Plain text: https://secwatch.observer/filing/0000950170-24-133817.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
